Hi All,
I’ve been invested in A2M since 2018 despite holding a significant loss on paper. Though I haven’t sold a single share as I truly believe in the fundamentals and the value proposition that the company will bring.
I was going through the annual meeting presentation pack and noticed the company is re-targeting a SAMR approval in late 2022.
Thoughts on A2 Company’s track/success in maintaining the SAMR approval?
- Forums
- ASX - By Stock
- A2M
- SAMR Approval Late 2022
SAMR Approval Late 2022
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.91 |
Change
0.010(0.17%) |
Mkt cap ! $4.278B |
Open | High | Low | Value | Volume |
$6.03 | $6.07 | $5.90 | $11.65M | 1.965M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5500 | $5.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.91 | 2504 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 11972 | 5.890 |
2 | 31393 | 5.880 |
2 | 12054 | 5.870 |
2 | 9980 | 5.860 |
3 | 1150 | 5.850 |
Price($) | Vol. | No. |
---|---|---|
5.910 | 2504 | 1 |
5.920 | 8176 | 2 |
5.940 | 4146 | 1 |
5.960 | 12222 | 4 |
5.970 | 24200 | 5 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online